Trial Profile
A randomized, double blind, parallel, placebo controlled, exploratory study to assess the effect of EA-230 on renal function and on safety and tolerability in patients at increased risk of developing renal failure following major cardiac on-pump surgery.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2014
Price :
$35
*
At a glance
- Drugs EA 230 (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 03 Dec 2014 New trial record